ArticleScientific reports2021

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE.

Anje Cauwels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.